人間拡張市場：タイプ別、機能別、最終用途別-2024-2030年の世界予測

人間拡張市場規模は2023年に2,558億4,000万米ドルと推定され、2024年には2,962億4,000万米ドルに達すると予測され、CAGR 15.96％で2030年には7,214億4,000万米ドルに達すると予測されます。

人間拡張には、技術やさまざまな手段を用いて人間の身体や精神の能力や特性を向上させることが含まれます。技術装置、インプラント、人工装具などの外部コンポーネントを統合して人間の機能を強化し、人間の自然な能力を超えることを含みます。人間拡張テクノロジーには、身体的強化、認知機能の向上、感覚の拡張、バイオハッキングなど、さまざまな応用が含まれます。認知機能強化や身体機能強化のアプリケーションに対する認識と受容の高まりが、マーケット成長の触媒となっています。兵士の身体的・認知的能力を強化するための軍事分野における人間拡張技術の応用拡大が市場成長の原動力となっています。人間拡張技術の使用や応用に関する普遍的な基準やガイドラインがないことが市場成長の妨げとなっています。さらに、人間拡張技術の研究開発、最終的な応用に関連する高コストが市場成長を阻害しています。市場ベンダーによるロボット工学、人工知能、バイオテクノロジーなどの分野における急速な開拓は、より高度で効果的な人間拡張デバイスやソリューションの創出を可能にします。これらは市場成長の機会を生み出すと期待されます。

タイプハンズフリーでのデータアクセスやナビゲーション案内を提供する拡張現実機器の利用拡大

拡張現実（AR）機器は、物理的世界にデジタル情報や仮想オブジェクトを重ね合わせるウェアラブル技術です。ユーザー体験と生産性を向上させるニーズに応えるものです。これらの機器は、ハンズフリーでのデータアクセスやナビゲーション・ガイドを提供できるため、高い需要があります。指紋／虹彩スキャナーや顔認識システムなどのバイオメトリクス技術は、認証や識別に使用され、利便性と安全性のために好まれています。バイオメトリクス・システムは、生理学的または行動学的特徴に基づいて生きている人の身元を確認または特定するための自動化された方法です。外骨格は、人間の能力と連動する装着可能な移動機械です。外骨格は胴体や手足に装着し、動力付きの関節やリンクを使用して強度と持久力を向上させる。外骨格は、人間の運動能力を補助し、身体作業を容易にするために使用されることが多いです。インテリジェント・バーチャルアシスタント（IVA）は、音声コマンドや自然言語を理解し、人間のさまざまな作業を支援するソフトウェア・エージェントです。IVAは、インターネットに接続されたさまざまな機器やプラットフォームに組み込まれ、人間の能力を便利かつハンズフリーで拡張します。バーチャルリアリティ（VR）デバイスは、ユーザーを没入型のコンピュータ生成環境に誘います。VRはゲーム、エンターテインメント、教育、トレーニング、シミュレーションなどに利用されています。VRを通じて提供される没入感の高い体験は、人間の知覚、認知、身体能力を拡張します。ウェアラブル・デバイスは、衣服やアクセサリーに組み込まれて機能を強化します。より高度なウェアラブルは、拡張現実ディスプレイを提供したり、眼球運動や脳活動を追跡したり、人間の体力や持久力を強化したりすることができます。

機能性：身体装着型人間拡張の利用が増加し、移動力と持久力が強化される

身体装着型人間拡張は、外骨格、ウェアラブルヘルスモニター、義肢などの身体に物理的に装着され、身体能力を強化するデバイスを含みます。これらの身体装着型機器は、製造業やヘルスケア産業において、個人の筋力、運動能力、持久力を強化するために使用されることが多いです。非身体装着型人間拡張には、認知または感覚の増強に焦点を当てた、身体的な装着なしに機能強化を提供するニューロテクノロジーおよび埋め込み型デバイスを含むデバイスが含まれます。これらの技術は、身体への物理的な装着を必要とせず、多くの場合、認知または感覚の増強に焦点を当てています。

エンドユーザー：製造業における人間拡張技術の応用拡大による作業員の生産性と効率の向上

航空宇宙・防衛分野では、人間拡張テクノロジーは身体的・認知的能力を強化し、優れたパフォーマンスと安全性を確保するために採用されています。人間拡張のエキソスーツや外骨格は、兵士の体力と持久力を強化し、長時間の任務における疲労を軽減し、機動性を向上させます。ヘルスケアでは、人間拡張テクノロジーは、リハビリテーション、患者ケア、障害者の生活の質の向上に重要な役割を果たしています。義肢装具人間拡張は、切断者のモビリティと生活の質を向上させます。ウェアラブルモニターやヘルストラッキング機器は、慢性疾患の管理をサポートし、患者やヘルスケアプロバイダーにリアルタイムの健康データを提供します。人間拡張テクノロジーは、製造業において作業者の生産性、安全性、効率性を向上させるために不可欠です。外骨格ウェアラブルデバイスは、特に力仕事や反復作業を伴う産業において、作業者の身体的負担を軽減します。人間拡張テクノロジーは、メディア＆エンターテインメント分野で没入体験と創造的な可能性を提供します。これらのテクノロジーは、没入型ゲーム、インタラクティブなストーリーテリング、テーマパークや娯楽施設での体験の充実を可能にします。

地域別インサイト

南北アメリカの人間拡張市場は、ロボット工学、人工知能、拡張現実の継続的な進歩に注力するネイティブプレーヤーが存在するため、非常に新興国市場です。北米、特に米国は、外骨格、ニューラル・コントロール・インターフェイス、義肢装具技術への投資が増加しており、主要な貢献国となっています。この地域は、ヘルスケア、軍事、産業分野で人間の能力強化に注力しており、市場拡大に拍車をかけています。APAC 人間拡張市場は、同地域のヘルスケアおよび製造部門の拡大により顕著な成長を遂げています。日本や韓国などの国々は、ヘルスケアや高齢者介護用途のロボット外骨格やウェアラブルデバイスの開発で最先端を走っています。APAC地域の市場は、人間拡張技術の幅広い採用を反映して、医療機器や産業用外骨格を含む多様なアプリケーションによって特徴付けられています。現在進行中のバイオニックアイの調査や欧州委員会からの多額の資金援助により、人間拡張への関心が高まっており、欧州における市場成長の基盤となっています。中東・アフリカ地域の人間拡張市場は、バイオニック義肢やヘルスケア・リハビリテーションのための支援技術への投資によって成長しています。この地域の研究開発への取り組みと相まって、多様な用途がEMEA全体の人間拡張市場の拡大に貢献しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは人間拡張市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、人間拡張市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.人間拡張市場の市場規模および予測は？

2.人間拡張市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.人間拡張市場の技術動向と規制枠組みは？

4.人間拡張市場における主要ベンダーの市場シェアは？

5.人間拡張市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 認知能力と身体能力を高めるアプリケーションに対する認識と受容の高まり
    • 医療用ウェアラブルデバイスに対する人間拡張の需要の高まり
    • 航空宇宙および防衛分野におけるジェスチャートラッキングの需要増加
  • 抑制要因
    • 人間拡張技術の開発コストが高い
  • 機会
    • 技術的に高度な人間拡張の継続的なイントロダクション
    • 技術の発展に向けた政府の支援と民間投資
  • 課題
    • 人間拡張テクノロジーの使用によるデータおよび個人情報漏洩のリスク
• 市場セグメンテーション分析
  • タイプ：ハンズフリーのデータアクセスとナビゲーションガイダンスを提供するための拡張現実デバイスの使用拡大
  • 機能性：身体に装着する人間拡張の使用を増やし、機動性と持久力を高める
  • エンドユーザー：製造業における人間拡張テクノロジーの適用を拡大し、労働者の生産性と効率性を向上させる
• 市場動向分析
  • 南北南北アメリカの軍事および防衛における人間拡張製品の導入拡大
  • APAC地域における画期的な人間拡張技術の開発に向けた研究開発に重点を置く
  • EMEA地域の航空宇宙および防衛分野における革新的な人間拡張技術の開発とアプリケーションの拡大に向けた多額の投資
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 人間拡張市場：タイプ別

• 拡張現実デバイス
• 生体認証システム
• 外骨格
• インテリジェントな仮想アシスタント
• バーチャルリアリティデバイス
• ウェアラブルデバイス

第7章 人間拡張市場機能別

• ボディウェア
• 非身体装着型

第8章 人間拡張市場：最終用途別

• 航空宇宙および防衛
• ヘルスケア
• 製造業
• メディアとエンターテイメント

第9章 南北アメリカの人間拡張市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の人間拡張市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの人間拡張市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • GoogleとQualcommが提携しウェアラブルデバイス向けRISC-Vチップを開発
  • Vuzix、Quanta Computerとパートナーシップ契約を締結
  • Humane、OpenAI搭載ウェアラブル「AI Pin」を正式に発売
  • 人間のつながりを実現する：Phantom Neuroが人間拡張とIoTを融合
  • SFUの研究者が開発したXoMotionは、移動が困難な人のための世界で最も先進的な外骨格となる
  • デュポン、STマイクロエレクトロニクス（ST）と提携し、生体信号をモニタリングする新しいスマートウェアラブルデバイスのコンセプトを開発
  • ウェアラブル企業OuraがデジタルIDスタートアップProxyを買収
  • 防衛における人間の能力を高めるための斬新な人間拡張イノベーションに200万ユーロの資金提供
  • ARIA調査、シドニーに人間拡張研究所を建設するために140万米ドルの助成金を獲得
  • Ekso Bionics、パーカー・ハネフィン社からIndego製品ラインを含むヒューマンモーション＆コントロール事業部門の買収を発表
  • 京セラ、人間の能力を高める先進的なAIを搭載した新人間拡張技術プロトタイプを日本で発表
  • Dasaが新たなイノベーション重点分野を開始：人間拡張（HA）
  • パリのスタートアップ企業が人間用外骨格の開発に4,500万米ドルを調達

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. HUMAN AUGMENTATION MARKET RESEARCH PROCESS
• FIGURE 2. HUMAN AUGMENTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. HUMAN AUGMENTATION MARKET DYNAMICS
• FIGURE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HUMAN AUGMENTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 45. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 46. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 47. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 48. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 49. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 50. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 51. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 52. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 53. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 54. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 55. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 56. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 57. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 58. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 59. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 60. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 61. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 62. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 63. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 64. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 65. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 66. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 67. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 68. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 71. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 72. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 73. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 74. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 75. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 76. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 80. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 82. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 84. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 85. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 86. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 87. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 88. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 89. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 90. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 91. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 92. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 93. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 94. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 95. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 96. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 97. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 98. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 99. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 100. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 101. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 102. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 103. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 104. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 105. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 106. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 107. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 108. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 109. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 110. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 111. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 112. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 113. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 114. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 115. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 116. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 117. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 118. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 119. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 120. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 121. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 122. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 123. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 124. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 125. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 126. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 127. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 130. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 131. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 132. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 134. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 136. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 137. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 138. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 139. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 140. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 141. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 142. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 143. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 144. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 145. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 146. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 147. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 148. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 149. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 150. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 151. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 152. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 153. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 154. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 155. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 156. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 163. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 164. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 165. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 166. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 167. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 168. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 169. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 170. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 171. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 172. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 173. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 174. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 175. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 176. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 177. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 178. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 179. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 180. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 181. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 182. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 183. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 184. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 185. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 186. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 187. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 188. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 189. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 190. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 191. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 192. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 193. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 194. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 195. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 196. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 197. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 198. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 199. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 200. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 201. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 202. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 203. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 204. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 205. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 206. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 207. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 208. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 209. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 210. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 211. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 212. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 213. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 214. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 215. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 216. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 217. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 218. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 219. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 220. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 221. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 222. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 223. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 224. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 225. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 226. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 227. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 228. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 229. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 230. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 231. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 232. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 233. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 234. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 235. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 236. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 237. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 238. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 239. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 240. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 241. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 242. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 244. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 246. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 247. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 248. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 252. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 253. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 254. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 255. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 256. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 257. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 258. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 259. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 260. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 261. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 262. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 263. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 264. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 265. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 266. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 267. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 268. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 269. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 270. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 271. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 272. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 273. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 274. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 275. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 276. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 277. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 278. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 282. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 283. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 284. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 286. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
• TABLE 288. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
• TABLE 289. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 290. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 291. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 292. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

[185 Pages Report] The Human Augmentation Market size was estimated at USD 255.84 billion in 2023 and expected to reach USD 296.24 billion in 2024, at a CAGR 15.96% to reach USD 721.44 billion by 2030.

Human augmentation includes using technology and various means to improve the capabilities and attributes of the human body and mind. It involves integrating external components, such as technological devices, implants, and prosthetics, to enhance human functions, extending beyond natural human capabilities. Human augmentation technologies encompass various applications, including physical enhancements, cognitive improvements, sensory augmentations, and biohacking. Growing awareness and acceptance of cognitive and physical enhancement applications serve as catalysts for market growth. Expanding the application of human augmentation technologies in the military to enhance soldiers' physical and cognitive capabilities is driving market growth. The lack of universal standards and guidelines regarding using and applying human augmentation technologies hampers market growth. Additionally, high costs associated with research, development, and the eventual application of human augmentation technologies impede market growth. Rapid developments in fields such as robotics, artificial intelligence, and biotechnology by market vendors enable the creation of more advanced and effective human augmentation devices and solutions. They are expected to create opportunities for market growth.

Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance

Augmented reality (AR) devices are wearable technologies that overlay digital information and virtual objects in the physical world. They meet the need for enhanced user experiences and productivity. These devices are in high demand due to their ability to provide hands-free data access and navigation guidance. Biometric technologies such as fingerprint/iris scanners and facial recognition systems are used for authentication and identification and are preferred for convenience and security. Biometric systems are automated methods for verifying or specifying the identity of a living person based on a physiological or behavioral characteristic. Exoskeletons are wearable mobile machines that work in conjunction with human capabilities. They fit around the torso and limbs and use powered joints and links to increase strength and endurance. Exoskeletons are often used to aid human mobility and make physical tasks easier. Intelligent virtual assistants (IVAs) are software agents that understand voice commands and natural language to assist humans with various tasks. IVAs are integrated into various internet-connected devices and platforms to augment human capabilities conveniently and hands-freely. Virtual reality (VR) devices transport users into an immersive computer-generated environment. VR is used for gaming, entertainment, education, training, and simulation. The highly immersive experience offered through VR augments human perception, cognition, and physical capabilities. Wearable devices are integrated into clothing or accessories items to enhance capabilities. More advanced wearables could provide augmented reality displays, track eye movements and brain activity, and enhance human physical strength or endurance.

Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance

Body-worn human augmentation involves devices physically attached to the body, such as exoskeletons, wearable health monitors, and prosthetics, enhancing physical abilities. These body-worn human devices are often used in manufacturing and healthcare industries to enhance strength, mobility, and endurance of individuals. Non-body-worn human augmentation includes devices, including neurotechnology and implantable devices that provide enhancements without physical attachment, focusing on cognitive or sensory augmentation. These technologies do not require physical attachment to the body and are often focused on cognitive or sensory augmentation.

End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency

In the aerospace & defense sector, human augmentation technologies are employed to enhance physical and cognitive abilities, ensuring superior performance and safety. Exosuits and exoskeletons human augmentation devices augment soldiers' physical strength and endurance, reducing fatigue during long missions and providing enhanced mobility. In healthcare, human augmentation technologies play a crucial role in rehabilitation, patient care, and improving the quality of life of individuals with disabilities. Prosthetic human augmentation enhances mobility and quality of life for amputees. Wearable monitors and health-tracking devices assist in managing chronic conditions and provide real-time health data for patients and healthcare providers. Human augmentation technologies are integral in the manufacturing sector to improve worker productivity, safety, and efficiency. Exoskeletons wearable devices reduce the physical strain on workers, particularly in industries involving heavy lifting or repetitive tasks. Human augmentation technologies offer immersive experiences and creative possibilities in the media & entertainment sector. These technologies enable immersive gaming, interactive storytelling, and enhanced experiences in theme parks and entertainment venues.

Regional Insights

The human augmentation market in the Americas represents a highly developing landscape due to the presence of native market players focusing on continuous advancements in robotics, artificial intelligence, and augmented reality. North America, particularly the United States, has been a key contributor, with increasing investments in exoskeletons, neural control interfaces, and prosthetic technologies. The region's focus on enhancing human capabilities in healthcare, military, and industrial sectors has spurred market expansion. The APAC human augmentation market has witnessed notable growth due to the region's expanding healthcare and manufacturing sectors. Countries such as Japan and South Korea have been at the forefront of developing robotic exoskeletons and wearable devices for healthcare and elderly care applications. APAC region's market is characterized by diverse applications, including medical devices and industrial exoskeletons, reflecting the wide adoption of human augmentation technologies. Ongoing research in bionic eye installations and considerable funding support from the European Commission underlined the growing interest in human augmentation, creating a platform for market growth in Europe. The Middle East and Africa regions human augmentation market is growing with investments in bionic limbs and assistive technologies for healthcare and rehabilitation. The diverse range of applications, coupled with the region's commitment to research and development, has contributed to expanding the human augmentation market throughout EMEA.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Augmentation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Augmentation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Augmentation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amazon.com, Inc., Apple Inc., AppliedVR, Inc., Aptima, Inc., Atheer, Inc., B-Temia Inc., Charles River Analytics, Inc., Cionic, Inc., Cognitive Mill by AIHunters, Continental AG, CYBERDYNE Inc., Ekso Bionics Holdings, Inc., Esper Bionics Inc., Fujitsu Limited, Garmin Limited, General Motors Company, Google LLC by Alphabet, Inc., HID Global Corporation by Assa Abloy AB, Hocoma AG by DIH International Limited, HTC Corporation, Hyundai Motor Company, IDEMIA Group, S.A.S., Kyocera Corporation, Lifesense Group, Magic Leap Inc., Meta Platforms, Inc., Microsoft Corporation, NEC Corporation, Nvidia Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Rewalk Robotics Inc., Rex Bionics Ltd, Robert Bosch GmbH, RTX Corporation, Saab AB, Samsung Electronics Co., Ltd., Soar Technology, Inc., Sony Group Corporation, Thales Group, Unity Software Inc., and Vuzix Corporation.

Market Segmentation & Coverage

This research report categorizes the Human Augmentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Augmented Reality Device
  • Biometric System
  • Exoskeletons
  • Intelligent Virtual Assistants
  • Virtual Reality Device
  • Wearable Device

• Functionality
  • Body Worn
  • Non-Body Worn

• End-use
  • Aerospace & Defense
  • Healthcare
  • Manufacturing
  • Media & Entertainment

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Human Augmentation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Augmentation Market?

3. What are the technology trends and regulatory frameworks in the Human Augmentation Market?

4. What is the market share of the leading vendors in the Human Augmentation Market?

5. Which modes and strategic moves are suitable for entering the Human Augmentation Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing awareness and acceptance of cognitive and physical enhancement applications
    • 5.1.1.2. Rising need for human augmentation for medical wearable devices
    • 5.1.1.3. Increasing demand from aerospace & defense for gesture-tracking purposes
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of human augmentation technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous introduction of technologically advanced human augmentation
    • 5.1.3.2. Government support and private investments for advancing human augmentation technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of data and identity breach with the usage of human augmentation technologies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance
  • 5.2.2. Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance
  • 5.2.3. End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency
• 5.3. Market Trend Analysis
  • 5.3.1. Increasing deployment of human augmentation products across military and defense of the Americas
  • 5.3.2. Emphasis on R&D for development of breakthrough human augmentation technologies in the APAC region
  • 5.3.3. Substantial investments to develop innovative human augmentation technologies and expanding applications in aerospace & defense sector in the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Human Augmentation Market, by Type

• 6.1. Introduction
• 6.2. Augmented Reality Device
• 6.3. Biometric System
• 6.4. Exoskeletons
• 6.5. Intelligent Virtual Assistants
• 6.6. Virtual Reality Device
• 6.7. Wearable Device

7. Human Augmentation Market, by Functionality

• 7.1. Introduction
• 7.2. Body Worn
• 7.3. Non-Body Worn

8. Human Augmentation Market, by End-use

• 8.1. Introduction
• 8.2. Aerospace & Defense
• 8.3. Healthcare
• 8.4. Manufacturing
• 8.5. Media & Entertainment

9. Americas Human Augmentation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Human Augmentation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Human Augmentation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Google and Qualcomm Partner to Make RISC-V Chip for Wearable Devices
  • 12.3.2. Vuzix Enters into a Partnership Agreement with Quanta Computer
  • 12.3.3. Humane Officially Launches the AI Pin, its OpenAI-powered Wearable
  • 12.3.4. Enabling Human Connectivity: Phantom Neuro Merges Human Augmentation and IoT
  • 12.3.5. XoMotion Created by SFU Researchers to be World's most Advanced Exoskeleton for Mobility Challenged
  • 12.3.6. DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals
  • 12.3.7. Wearable Company Oura Acquires Digital Identification Startup Proxy
  • 12.3.8. EUR 2 Million Funding for Novel Human Augmentation Innovations to Enhance Human Capability in Defense
  • 12.3.9. ARIA Research Receives USD 1.4 Million in Grant Funding to Build Human Augmentation Laboratory in Sydney
  • 12.3.10. Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego Product Line from Parker Hannifin Corporation
  • 12.3.11. KYOCERA Introduces New Human Augmentation Technology Prototypes in Japan with Advanced AI to Enhance Human Abilities
  • 12.3.12. Dasa Launches New Innovation Focus Area: Human Augmentation (HA)
  • 12.3.13. A Parisian Startup just Raised USD 45 Million to Build Human Exoskeletons

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio